These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33039965)

  • 1. Decreased complement C3 levels are associated with poor prognosis in patients with COVID-19: A retrospective cohort study.
    Fang S; Wang H; Lu L; Jia Y; Xia Z
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107070. PubMed ID: 33039965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study.
    Zhang J; Wang Z; Wang X; Hu Z; Yang C; Lei P
    Front Immunol; 2021; 12():581469. PubMed ID: 33664741
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of blood analysis and immune function on the prognosis of patients with COVID-19.
    Fu YQ; Sun YL; Lu SW; Yang Y; Wang Y; Xu F
    PLoS One; 2020; 15(10):e0240751. PubMed ID: 33125396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deregulated cellular circuits driving immunoglobulins and complement consumption associate with the severity of COVID-19 patients.
    Marcos-Jiménez A; Sánchez-Alonso S; Alcaraz-Serna A; Esparcia L; López-Sanz C; Sampedro-Núñez M; Mateu-Albero T; Sánchez-Cerrillo I; Martínez-Fleta P; Gabrie L; Del Campo Guerola L; Rodríguez-Frade JM; Casasnovas JM; Reyburn HT; Valés-Gómez M; López-Trascasa M; Martín-Gayo E; Calzada MJ; Castañeda S; de la Fuente H; González-Álvaro I; Sánchez-Madrid F; Muñoz-Calleja C; Alfranca A
    Eur J Immunol; 2021 Mar; 51(3):634-647. PubMed ID: 33251605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement C3 identified as a unique risk factor for disease severity among young COVID-19 patients in Wuhan, China.
    Cheng W; Hornung R; Xu K; Yang CH; Li J
    Sci Rep; 2021 Apr; 11(1):7857. PubMed ID: 33846344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Complement C3 and C4 and COVID-19 Severity and Mortality: A Systematic Review and Meta-Analysis With Meta-Regression.
    Zinellu A; Mangoni AA
    Front Immunol; 2021; 12():696085. PubMed ID: 34163491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement Overactivation and Consumption Predicts In-Hospital Mortality in SARS-CoV-2 Infection.
    Sinkovits G; Mező B; Réti M; Müller V; Iványi Z; Gál J; Gopcsa L; Reményi P; Szathmáry B; Lakatos B; Szlávik J; Bobek I; Prohászka ZZ; Förhécz Z; Csuka D; Hurler L; Kajdácsi E; Cervenak L; Kiszel P; Masszi T; Vályi-Nagy I; Prohászka Z
    Front Immunol; 2021; 12():663187. PubMed ID: 33841446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19.
    Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X
    Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factor Analysis and Nomogram Construction for Non-Survivors among Critical Patients with COVID-19.
    Wang B; Zhong F; Zhang H; An W; Liao M; Cao Y
    Jpn J Infect Dis; 2020 Nov; 73(6):452-458. PubMed ID: 32611979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The evaluation of the immune status of COVID-19 recovered subjects with persistent abnormal lung CT after one year: A longitudinal cohort study.
    Chi H; Zhou K; Shen L; Xu J; Li J; Chen S; Wu X; Tung TH; Shen B; Zhu H
    Int Immunopharmacol; 2022 Sep; 110():109019. PubMed ID: 35816945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
    Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
    BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement and sepsis.
    Gutiérrez-Fernández J; Maroto MC; Piédrola G; Zamora E
    Allergol Immunopathol (Madr); 1987; 15(3):145-9. PubMed ID: 3661354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulins and complement in migraine.
    Jerzmanowski A; Klimek A
    Cephalalgia; 1983 Jun; 3(2):119-23. PubMed ID: 6871986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement levels at admission as a reflection of coronavirus disease 2019 (COVID-19) severity state.
    Henry BM; Szergyuk I; de Oliveira MHS; Lippi G; Benoit JL; Vikse J; Benoit SW
    J Med Virol; 2021 Sep; 93(9):5515-5522. PubMed ID: 33974276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased C4 and decreased C3 levels are associated with a poor prognosis in patients with immunoglobulin A nephropathy: a retrospective study.
    Pan M; Zhang J; Li Z; Jin L; Zheng Y; Zhou Z; Zhen S; Lu G
    BMC Nephrol; 2017 Jul; 18(1):231. PubMed ID: 28697742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune inflammation factors associated with disease severity and poor prognosis in patients with COVID-19: A retrospective cohort study.
    Kang Y; Lu S; Zhong R; You J; Chen J; Li L; Huang R; Xie Y; Chen F; Chen J; Chen L
    Heliyon; 2024 Jan; 10(1):e23583. PubMed ID: 38173531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reciprocal changes in serum levels of immunoglobulins (IgG, IgA, IgM) and complements (C3, C4) in normal pregnancy and after delivery.
    Yasuhara M; Tamaki H; Iyama S; Yamaguchi Y; Tachi J; Amino N
    J Clin Lab Immunol; 1992; 38(3):137-41. PubMed ID: 1345750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed discharge is associated with higher complement C3 levels and a longer nucleic acid-negative conversion time in patients with COVID-19.
    Lin P; Chen W; Huang H; Lin Y; Cai M; Lin D; Cai H; Su Z; Zhuang X; Yu X
    Sci Rep; 2021 Jan; 11(1):1233. PubMed ID: 33441900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of serum IgA/C3 and glomerular C3 staining on clinical prognosis in patients with IgA nephropathy].
    Pei GQ; Qin AY; Wang SQ; Tan L; Tang Y; Qin W
    Zhonghua Yi Xue Za Zhi; 2020 Aug; 100(30):2372-2377. PubMed ID: 32791814
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of serum C3 levels with the risk of myocardial infarction.
    Muscari A; Bozzoli C; Puddu GM; Sangiorgi Z; Dormi A; Rovinetti C; Descovich GC; Puddu P
    Am J Med; 1995 Apr; 98(4):357-64. PubMed ID: 7709948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.